Development and validation of a m(6)A -regulated prognostic signature in lung adenocarcinoma

Lung adenocarcinoma (LUAD) is the most frequent subtype of lung cancer, with a 5-year survival rate of less than 20%. N6-methyladenosine (m(6)A) is the most prevalent RNA epigenetic modification in eukaryotic cells, and post-transcriptionally regulates gene expression and function by affecting RNA m...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yaxin, Xia, Lei, Peng, Yuxuan, Wang, Gang, Bi, Liyun, Xiao, Xue, Li, Cui, Li, Weimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593055/
https://www.ncbi.nlm.nih.gov/pubmed/36303829
http://dx.doi.org/10.3389/fonc.2022.947808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593055/
https://www.ncbi.nlm.nih.gov/pubmed/36303829
http://dx.doi.org/10.3389/fonc.2022.947808

Ejemplares similares